慢性阻塞性肺疾病患者肺泡灌洗液中IL-17和IL-23检测的意义

doi:10.3969/j.issn.1673-8640.2013.10.007

检验医学 ›› 2013, Vol. 28 ›› Issue (10): 893-896.DOI: 10.3969/j.issn.1673-8640.2013.10.007

慢性阻塞性肺疾病患者肺泡灌洗液中IL-17和IL-23检测的意义

牟皎月，叶廷军，樊绮诗

上海交通大学医学院附属瑞金医院检验科，上海 200025

收稿日期:2013-02-06 出版日期:2013-10-30 发布日期:2013-10-29
通讯作者: 樊绮诗，联系电话:021-64370045。
作者简介:牟皎月，女，1971年生，主管技师，主要从事自身免疫性疾病研究。

Clinical significance on the determinations of IL-17 and IL-23 from bronchoalveolar lavage fluid in patients with chronic obstructive pulmonary disease

MOU Jiaoyue,YE Tingjun,FAN Qishi.

Department of Clinical Laboratory,Ruijin Hospital,Shanghai Jiaotong University School of Medicine,Shanghai 200025, China

Received:2013-02-06 Online:2013-10-30 Published:2013-10-29

摘要/Abstract

摘要：

目的检测慢性阻塞性肺疾病(COPD)患者支气管肺泡灌洗液(BALF)中白细胞介素17(IL-17)、白细胞介素23(IL-23)在发病过程中的变化，为临床判断和了解COPD的炎症发展提供依据。方法参照BALF的细胞百分计数分类、临床资料及肺功能第1秒用力呼气容积占预计值百分比(FEV1%)实验对COPD急性期组、COPD 缓解期组及非COPD对照组分别进行检测。采用酶联免疫吸附试验(ELISA)对BALF中IL-17、IL-23 的浓度进行测定。结果 COPD急性期组BALF中IL-17、IL-23 的浓度较COPD 缓解期组、对照组明显增加(P<；0.01)；COPD 急性期组FEV1%较COPD 缓解期组和对照组亦明显增加(P<；0.01)；COPD 患者BALF中IL-23与IL-17浓度呈直线正相关(r²=0.698 5，P<；0.001)，COPD患者BALF中IL-17、IL-23浓度与FEV1%均呈直线负相关(r²=-0.527 9、-0.541 0，P均<；0.001)。结论肺局部炎症时IL-17、IL-23的浓度与COPD 的变化和临床症状呈一定的相关性，其中IL-17的浓度与局部炎症情况相关性较IL-23强，其浓度的维持可能与炎症的持续存在有一定关系。检测COPD患者BALF中IL-17、IL-23水平对病情判断和治疗具有指导意义。

关键词: 白细胞介素 17, 白细胞介素 23, 支气管肺泡灌洗液, 慢性阻塞性肺疾病

Abstract:

Objective To determine the changes of interleukin 17 (IL-17) and interleukin 23 (IL-23) from bronchoalveolar lavage fluid (BALF) in patients with chronic obstructive pulmonary disease(COPD), and to provide the reference for diagnosing and understanding the inflammation development of COPD. Methods On the basis of cytological classification for BALF, clinical data and forced expiratory volume in first second to forced vital capacity ratio(FEV1%), acute exacerbation COPD group, stable phase COPD group and non-COPD control group were determined, respectively. The IL-17 and IL-23 levels were determined by enzyme-linked immunosorbent assay (ELISA). Results The IL-17 and IL-23 levels and FEV1% increased more significantly in acute exacerbation COPD group than in stable phase COPD group and control group (P<0.01) . There was a positive linear correlation between BALF IL-17 and IL-23 in COPD groups (r²=0.698 5,P<0.001), however, there was a negative linear correlation of BALF IL-17 and IL-23 with FEV1% in COPD groups (r²=-0.527 9 and -0.541 0, P<0.001). Conclusions The IL-17 and IL-23 levels with local lung inflammatory have correlations with the changes of COPD and the clinical manifestations,especially for IL-17,which may lead to persistent inflammation. Overall, the determinations of IL-17 and IL-23 are useful for the diagnosis and surveillance of COPD.

Key words: Interleukin 17, Interleukin 23, Bronchoalveolar lavage fluid, Chronic obstructive pulmonary disease

中图分类号:

R446.62

牟皎月，叶廷军，樊绮诗. 慢性阻塞性肺疾病患者肺泡灌洗液中IL-17和IL-23检测的意义[J]. 检验医学, 2013, 28(10): 893-896.

MOU Jiaoyue,YE Tingjun,FAN Qishi.. Clinical significance on the determinations of IL-17 and IL-23 from bronchoalveolar lavage fluid in patients with chronic obstructive pulmonary disease[J]. , 2013, 28(10): 893-896.

参考文献

[1] Morjaria JB,Malerba M,Polosa R. Biologic and pharmacologic therapies in clinical development for the inflammatory response in COPD [J]. Drug Discov Today,2010,15(9-10): 396-405.
[2] 夏婧,周影娜,张湘燕,等.慢性阻塞性肺疾病急性加重期患者血清中IL-17,MMP-9水平的变化及意义[J].贵州医药,2011,35(8):691-694.
[3] 中华医学会呼吸病学分会慢性阻塞性肺疾病学组.慢性阻塞性肺病诊治指南[J].中华结核和呼吸杂志,2002,25(8):453-460.
[4] 刘仁杰,万毅新,王晓平,等. 慢性阻塞性肺疾病患者血清IL- 17、IL- 23 水平及临床意义[J].重庆医科大学学报,2011,36(8):976-978.
[5] 王妹芳,王龙武,邓星奇.慢性阻塞性肺疾病患者外周血及痰中IL-8、IL-17及TGF-β水平的检测和意义[J].检验医学,2007,22(4):394-397.
[6] Di Stefano A,Caramori G,Gnemmi I,et al.T helper type 17-related cytokine expression is increased in the bronchial mucosa of stable chronic obstructive pulmonary disease patients[J]. Clin Exp Immunol,2009,157(2):316-324.
[7] Chen Y,Langrish CL,McKenzie B,et al.Anti-IL-23 therapy inhibits multiple inflammatory pathways and ameliorates autoimmune encephalomyelitis[J].J Clin Invest,2006,116(5):1317-1326.
[8] Langrish CL,McKenzie BS,Wilson NJ,et al.IL-12 and IL-23: master regulators of innate and adaptive immunity[J].Immunol Rev,2004,202:96-105.
[9] Liang SC,Long AJ,Bennett F,et al.An IL-17F/A heterodimer protein is produced by mouse Th17 cells and induces airway neutrophil recruitment[J]. J Immunol,2007,179(11): 7791-7799.
[10] 杨沫毅,向旭东.白介素23及其受体的致炎机能[J].国际呼吸杂志,2010,30(2):99-103.
[11] De Luca A,Rindi L,Celi A. Intracellular detection of interleukin 17 and other cytokines in human bronchoalveolar lavage fluid: a first assessment[J]. Immunol Lett,2011,141(2): 204-209.

[1]	马大文, 王宏俊, 胡莎莎. NLR、PLR联合MPV预测老年慢性阻塞性肺疾病患者急性加重期近期预后不良的价值[J]. 检验医学, 2022, 37(9): 850-854.
[2]	张颖, 刘慧玲. COPD合并感染患者血清甲状腺激素水平变化及其与低T₃综合征的关系[J]. 检验医学, 2022, 37(11): 1062-1065.
[3]	王晓清, 彭雪梅, 兰美锋, 潘敏. MCP-1联合CREWS在AECOPD患者不良预后评估中的价值[J]. 检验医学, 2022, 37(10): 934-938.
[4]	陈金来, 张菊英, 秦红, 赵津辉. 血清D-二聚体水平对预测老年慢性阻塞性肺疾病患者预后的价值[J]. 检验医学, 2021, 36(3): 309-312.
[5]	黄隽敏, 庄须翠, 秋爽. 慢性阻塞性肺疾病急性加重患者下呼吸道病原菌菌种分布及耐药性分析[J]. 检验医学, 2020, 35(8): 771-774.
[6]	闫佩毅, 张骥, 涂焕平, 张立, 仇越, 张锋英, 胡奕雯, 金姝. COPD患者痰液中性粒细胞氧化吞噬功能及相关受体变化的临床意义[J]. 检验医学, 2020, 35(6): 570-577.
[7]	张森, 莫光洲, 陈志锋, 梁松荣, 卢月梅, 林坤培. 多项血液指标对慢性阻塞性肺疾病长期死亡率的预测价值[J]. 检验医学, 2020, 35(2): 112-115.
[8]	付海卫, 孔一名, 李小波, 张添威, 戴元荣. SAA、CRP和ESR联合检测诊断AECOPD的临床价值[J]. 检验医学, 2018, 33(7): 586-589.
[9]	王永, 范远威, 吕伟. PCT、hs-CRP在AECOPD合并SIRS中的临床价值[J]. 检验医学, 2018, 33(1): 91-92.
[10]	徐庆雷, 周红, 马小波, 张巍, 刘玲玲, 刘刚, 张敏. 哮喘患儿支气管肺泡灌洗液GM-CSF和MPO水平的变化及意义[J]. 检验医学, 2017, 32(7): 603-606.
[11]	顾峰. 慢性阻塞性肺疾病急性加重期患者血清25-羟基维生素D检测的临床意义[J]. 检验医学, 2016, 31(7): 559-561.
[12]	王永, 傅士靖, 陈如健, 吕伟. 降钙素原测定在慢性阻塞性肺疾病急性加重期的临床意义[J]. 检验医学, 2016, 31(2): 91-94.
[13]	季伟星, 周兴辉, 王鑫华, 金慧英, 郑瑶, 陈晓. 血浆PCT水平与AECOPD合并心力衰竭患者心功能的关系[J]. 检验医学, 2016, 31(10): 874-877.
[14]	廖长征, 徐文莉, 陈思祖. 慢性阻塞性肺疾病患者外周血T淋巴细胞凋亡检测的临床价值[J]. 检验医学, 2015, 30(10): 971-974.
[15]	朱国民. 降钙素原与C反应蛋白联合检测在慢性阻塞性肺疾病急性加重期的临床价值[J]. 检验医学, 2014, 29(12): 1246-1247.

慢性阻塞性肺疾病患者肺泡灌洗液中IL-17和IL-23检测的意义

Clinical significance on the determinations of IL-17 and IL-23 from bronchoalveolar lavage fluid in patients with chronic obstructive pulmonary disease

RichHTML

PDF (PC)

可视化

被引次数

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics